The economic impact of reprocessing external fixation components.

The economic impact of reprocessing external fixation components. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The economic impact of reprocessing external fixation components. Abstract Text:

Daniel S Horwitz,Kathryn L S Schabel,Thomas F Higgins,

BACKGROUND: The trend toward temporizing external fixation of complex fractures has resulted in increased expenditures for these devices. Increasing pressure to reduce health-care expenditures has led to exploration of reuse of equipment intended for single use. Devices must be tested and recertified prior to redeployment in hospital stock. We report the rate of manufacturer recertification and institutional cost savings associated with a reuse program approved by the United States Food and Drug Administration. METHODS: All Hoffmann-II external fixation components that had been removed at our institution during the study period were submitted to the manufacturer for visual inspection and mechanical testing. Pass rates for original components and previously recycled components were determined. With use of a conservative pass rate and the assumption of a maximum of three recertifications of each component, the total potential hospital savings on external fixation were calculated. RESULTS: The first pass rate was 76%. The second pass rate (i.e., the rate for components that had already been recertified once and had been sent for a second recertification) was 83%, but that rate was derived from a limited sample. On the basis of a conservative pass-rate estimate of 75%, the predicted average number of uses of a recyclable component was 2.7. The recertified components were sold back to our hospital at 50% of the original price. Because carbon-fiber bars and half-pins are not recycled, 85% of the charges expended on a new external fixation component are spent on portions of the system that are recyclable. The potential total savings on reusable components was found to be 32%, with a total savings of 27% for the whole external fixation system. No recertified components failed in clinical use over the course of the study. CONCLUSIONS: With the expansion of cost-control efforts, the recycling of medical devices appears inevitable. Previous data have demonstrated the safety of reuse of external fixation devices, and this study confirms that finding. Our paper demonstrates the real cost savings associated with a manufacturer-based testing and recertification program. Issues of voluntary participation in reuse programs, component ownership, and the impact of savings on patient charges are yet to be worked out by individual institutions.

The economic impact of reprocessing external fixation components. Publishing Authors By Initials

DS Horwitz,KL Schabel,TF Higgins,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The economic impact of reprocessing external fixation components. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of bone and joint surgery. American vo

VOLUME: 89

Page Numbers: 2132-6

Journal Abbreviation:

ISSN: 0021-9355

DAY: 20

MONTH: Oct

YEAR: 2007

The economic impact of reprocessing external fixation components. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 14030

The economic impact of reprocessing external fixation components. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The economic impact of reprocessing external fixation components. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The economic impact of reprocessing external fixation components.

AFFILIATION: Department of Orthopaedics, University of Utah, 590 Wakara Way, Salt Lake City, UT 84108, USA. Dan.Horwitz@hsc.utah.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Bone Joint Surg Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The economic impact of reprocessing external fixation components Related Publications

• A bifunctional O-GlcNAc transferase governs flagellar motility through anti-repression.
• A navigation aid for the blind using tactile-visual sensory substitution.
• Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine.
• Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1.
• Bean alpha-amylase inhibitors in transgenic peas inhibit development of pea weevil larvae.
• Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism.
• Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media.
• Effects of elicitation task variables on speech production by children with cochlear implants.
• Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age.
• First inelastic neutron scattering studies on thin free standing polymer films.
• Gene expression, intron density, and splice site strength in Drosophila and Caenorhabditis.
• Genomic approaches to understanding bacterial virulence.
• Growth rate toxicity phenotypes and homeostatic supercoil control differentiate Escherichia coli from Salmonella enterica serovar Typhimurium.
• Impact of prenatal cocaine exposure on child behavior problems through school age.
• Microarray analysis of Mu transposition in Salmonella enterica, serovar Typhimurium: transposon exclusion by high-density DNA binding proteins.
• Mutational bias suggests that replication termination occurs near the dif site, not at Ter sites: what's the Dif?
• Opposing effects of 5-HT(2A) and 5-HT (2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
• Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons.
• PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.
• Patterns of sensitization to food and aeroallergens in the first 3 years of life.
• Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
• Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
• Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
• Should we be CHARMed?
• System for the analysis and visualization of large 3D anatomical trees.
• The TGF-beta1/Upstream Stimulatory Factor-Regulated PAI-1 Gene: Potential Involvement and a Therapeutic Target in Alzheimer's Disease.
• The economic impact of reprocessing external fixation components.
• The impact of a genetics education program on physicians' knowledge and genetic counseling referral patterns.
• The use of heparin in preparing samples for blood-gas analysis.
• iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer.